BMRN BioMarin Pharmaceutical | $80.91 -1.5% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $110.00 | Low | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 4/25/2024 |
HUM Humana | $305.91 -1.8% | 4/25/2024 | Target Lowered by | Cantor Fitzgerald | - | Neutral -> Neutral | $391.00 -> $360.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 4/25/2024 |
ENVX Enovix | $6.46 +10.6% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 | Low | View details for Cantor Fitzgerald rating of Enovix (NASDAQ:ENVX) on 4/25/2024 |
LRCX Lam Research | $925.37 +2.7% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $1,100.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 4/25/2024 |
TER Teradyne | $114.13 +4.8% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $110.00 | Low | View details for Cantor Fitzgerald rating of Teradyne (NASDAQ:TER) on 4/25/2024 |
AMED Amedisys | $91.79 +0.7% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $101.00 | Low | View details for Cantor Fitzgerald rating of Amedisys (NASDAQ:AMED) on 4/25/2024 |
|
TXN Texas Instruments | $177.48 +1.3% | 4/24/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $180.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 4/24/2024 |
ITCI Intra-Cellular Therapies | $73.26 +1.6% | 4/24/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $120.00 | Low | View details for Cantor Fitzgerald rating of Intra-Cellular Therapies (NASDAQ:ITCI) on 4/24/2024 |
ANNX Annexon | $4.70 +2.4% | 4/24/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Annexon (NASDAQ:ANNX) on 4/24/2024 |
STX Seagate Technology | $86.04 -1.4% | 4/24/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $95.00 -> $100.00 | Low | View details for Cantor Fitzgerald rating of Seagate Technology (NASDAQ:STX) on 4/24/2024 |
MTLS Materialise | $5.24 +3.1% | 4/24/2024 | Initiated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight | $9.50 | Low | View details for Cantor Fitzgerald rating of Materialise (NASDAQ:MTLS) on 4/24/2024 |
ABEO Abeona Therapeutics | $3.26 +2.2% | 4/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $36.00 | N/A | View details for Cantor Fitzgerald rating of Abeona Therapeutics (NASDAQ:ABEO) on 4/23/2024 |
CDTX Cidara Therapeutics | $12.63 -2.8% | 4/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Cidara Therapeutics (NASDAQ:CDTX) on 4/23/2024 |
INCY Incyte | $51.68 +1.0% | 4/23/2024 | Initiated by | Cantor Fitzgerald | - | Neutral | | Low | View details for Cantor Fitzgerald rating of Incyte (NASDAQ:INCY) on 4/23/2024 |
TSHA Taysha Gene Therapies | $2.39 +3.9% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 4/18/2024 |
ASND Ascendis Pharma A/S | $135.90 -0.8% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $173.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 4/18/2024 |
BHVN Biohaven | $38.99 +1.2% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 4/18/2024 |
GPCR Structure Therapeutics | $38.94 -0.1% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Structure Therapeutics (NASDAQ:GPCR) on 4/18/2024 |
MRK Merck & Co., Inc. | $131.19 +0.4% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 4/18/2024 |
NVO Novo Nordisk A/S | $126.86 +0.9% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $160.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 4/18/2024 |
CMPS COMPASS Pathways | $7.94 +1.0% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of COMPASS Pathways (NASDAQ:CMPS) on 4/18/2024 |
COUR Coursera | $11.97 +1.9% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $26.00 | Low | View details for Cantor Fitzgerald rating of Coursera (NYSE:COUR) on 4/17/2024 |
CRWD CrowdStrike | $304.07 +2.0% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $400.00 | N/A | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 4/17/2024 |
CYBR CyberArk Software | $242.60 -1.0% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $300.00 | N/A | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 4/17/2024 |
DDOG Datadog | $131.45 +5.0% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $150.00 | N/A | View details for Cantor Fitzgerald rating of Datadog (NASDAQ:DDOG) on 4/17/2024 |
FTNT Fortinet | $64.18 +0.2% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $65.00 | N/A | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 4/17/2024 |
NET Cloudflare | $87.98 +1.4% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $100.00 | N/A | View details for Cantor Fitzgerald rating of Cloudflare (NYSE:NET) on 4/17/2024 |
PANW Palo Alto Networks | $291.42 +0.9% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $350.00 | N/A | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 4/17/2024 |
ZS Zscaler | $177.05 +1.3% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $230.00 | N/A | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 4/17/2024 |
KVYO Klaviyo | $23.61 +2.6% | 4/16/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $31.00 | Low | View details for Cantor Fitzgerald rating of Klaviyo (NYSE:KVYO) on 4/16/2024 |
REGN Regeneron Pharmaceuticals | $883.20 -0.8% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $925.00 | Low | View details for Cantor Fitzgerald rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 4/15/2024 |
LLY Eli Lilly and Company | $733.51 +1.2% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $815.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 4/15/2024 |
JNJ Johnson & Johnson | $146.13 -0.5% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 4/15/2024 |
PFE Pfizer | $25.38 +0.5% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 4/15/2024 |
ALXO ALX Oncology | $16.86 -0.1% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of ALX Oncology (NASDAQ:ALXO) on 4/12/2024 |
PSNY Polestar Automotive Holding UK | $1.18 +0.9% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Polestar Automotive Holding UK (NASDAQ:PSNY) on 4/12/2024 |
MRVL Marvell Technology | $69.62 +3.2% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $85.00 | Low | View details for Cantor Fitzgerald rating of Marvell Technology (NASDAQ:MRVL) on 4/12/2024 |
HRMY Harmony Biosciences | $29.32 +1.3% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 | Low | View details for Cantor Fitzgerald rating of Harmony Biosciences (NASDAQ:HRMY) on 4/12/2024 |
PTCT PTC Therapeutics | $28.57 +12.1% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 4/12/2024 |
SOUN SoundHound AI | $4.40 +5.8% | 4/11/2024 | Upgraded by | Cantor Fitzgerald | - | Underweight -> Neutral | $4.90 | Low | View details for Cantor Fitzgerald rating of SoundHound AI (NASDAQ:SOUN) on 4/11/2024 |
If you have $2,500 bucks… check this out (Ad) This computer whiz has been averaging 234% per year with an undefeated strategy he calls…
The “Income Glitch”
And he’s been making out like a bandit with a 100% success rate on over 64 trade opportunities! Click here to unlock the Income Glitch training workshop for free. |
PRTA Prothena | $20.87 +1.5% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Prothena (NASDAQ:PRTA) on 4/10/2024 |
BHVN Biohaven | $38.99 +1.2% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 4/10/2024 |
RCM R1 RCM | $11.90 +0.7% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | Low | View details for Cantor Fitzgerald rating of R1 RCM (NASDAQ:RCM) on 4/10/2024 |
SGRY Surgery Partners | $24.55 -1.2% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $43.00 | Low | View details for Cantor Fitzgerald rating of Surgery Partners (NASDAQ:SGRY) on 4/10/2024 |
TBRG TruBridge | $8.04 +2.4% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of TruBridge (NASDAQ:TBRG) on 4/10/2024 |
THC Tenet Healthcare | $96.13 -1.4% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $104.00 | Low | View details for Cantor Fitzgerald rating of Tenet Healthcare (NYSE:THC) on 4/10/2024 |
UHS Universal Health Services | $166.06 +0.6% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Underweight -> Underweight | $156.00 | Low | View details for Cantor Fitzgerald rating of Universal Health Services (NYSE:UHS) on 4/10/2024 |
UNH UnitedHealth Group | $495.35 +0.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $591.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 4/10/2024 |
AWH Aspira Women's Health | $3.33 +1.5% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $3.30 | Low | View details for Cantor Fitzgerald rating of Aspira Women’s Health (NASDAQ:AWH) on 4/10/2024 |
ACAD ACADIA Pharmaceuticals | $16.71 +2.5% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $37.00 | Low | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 4/10/2024 |
AXSM Axsome Therapeutics | $71.71 +0.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 | Low | View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 4/10/2024 |
JAZZ Jazz Pharmaceuticals | $109.46 +1.9% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 4/10/2024 |
LBPH Longboard Pharmaceuticals | $19.72 +2.4% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 4/10/2024 |
MRNS Marinus Pharmaceuticals | $1.41 -0.7% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $28.00 | Low | View details for Cantor Fitzgerald rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 4/10/2024 |
NBIX Neurocrine Biosciences | $135.99 -1.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $155.00 | Low | View details for Cantor Fitzgerald rating of Neurocrine Biosciences (NASDAQ:NBIX) on 4/10/2024 |
XENE Xenon Pharmaceuticals | $40.50 +1.0% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 4/10/2024 |
CI The Cigna Group | $354.41 0.0% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Overweight -> Overweight | $384.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 4/10/2024 |
CVS CVS Health | $67.18 -0.2% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $87.00 | Low | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 4/10/2024 |
ELV Elevance Health | $537.26 -0.4% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $580.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 4/10/2024 |
HCA HCA Healthcare | $306.60 -2.4% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $335.00 | Low | View details for Cantor Fitzgerald rating of HCA Healthcare (NYSE:HCA) on 4/10/2024 |
HCAT Health Catalyst | $6.03 +7.7% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $16.00 | Low | View details for Cantor Fitzgerald rating of Health Catalyst (NASDAQ:HCAT) on 4/10/2024 |
HUM Humana | $305.91 -1.8% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $391.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 4/10/2024 |
AGIO Agios Pharmaceuticals | $31.49 -0.6% | 4/9/2024 | Reiterated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of Agios Pharmaceuticals (NASDAQ:AGIO) on 4/9/2024 |
VINC Vincerx Pharma | $0.73 -18.9% | 4/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Vincerx Pharma (NASDAQ:VINC) on 4/9/2024 |
GPCR Structure Therapeutics | $38.94 -0.1% | 4/9/2024 | Initiated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Structure Therapeutics (NASDAQ:GPCR) on 4/9/2024 |
NXPI NXP Semiconductors | $242.70 +1.9% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $270.00 -> $290.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 4/8/2024 |
KLAC KLA | $706.26 +4.9% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $625.00 -> $800.00 | Low | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 4/8/2024 |
LRCX Lam Research | $925.37 +2.7% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $900.00 -> $1,100.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 4/8/2024 |
MU Micron Technology | $114.84 +2.9% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $135.00 -> $150.00 | Low | View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 4/8/2024 |
QCOM QUALCOMM | $165.66 +1.4% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $150.00 -> $190.00 | Low | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 4/8/2024 |
TXN Texas Instruments | $177.48 +1.3% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $170.00 -> $180.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 4/8/2024 |
WDC Western Digital | $71.36 +2.8% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $70.00 -> $100.00 | Low | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 4/8/2024 |
GFS GLOBALFOUNDRIES | $48.39 +1.3% | 4/8/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Neutral | $70.00 -> $55.00 | Low | View details for Cantor Fitzgerald rating of GLOBALFOUNDRIES (NASDAQ:GFS) on 4/8/2024 |
AMAT Applied Materials | $203.38 +3.0% | 4/8/2024 | Upgraded by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Overweight | $220.00 -> $260.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 4/8/2024 |
CABA Cabaletta Bio | $11.01 -9.6% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 | Low | View details for Cantor Fitzgerald rating of Cabaletta Bio (NASDAQ:CABA) on 4/5/2024 |
RARE Ultragenyx Pharmaceutical | $44.24 +0.9% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 4/5/2024 |
ETNB 89bio | $8.26 +0.1% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $29.00 | Low | View details for Cantor Fitzgerald rating of 89bio (NASDAQ:ETNB) on 4/5/2024 |
MRK Merck & Co., Inc. | $131.19 +0.4% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 4/5/2024 |
MOH Molina Healthcare | $342.23 -2.9% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $406.00 | Low | View details for Cantor Fitzgerald rating of Molina Healthcare (NYSE:MOH) on 4/4/2024 |
UNH UnitedHealth Group | $495.35 +0.3% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $591.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 4/4/2024 |
SPRO Spero Therapeutics | $1.46 +2.1% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Spero Therapeutics (NASDAQ:SPRO) on 4/4/2024 |
STOK Stoke Therapeutics | $12.41 +6.2% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Stoke Therapeutics (NASDAQ:STOK) on 4/4/2024 |
ATAI Atai Life Sciences | $1.93 +4.9% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Atai Life Sciences (NASDAQ:ATAI) on 4/4/2024 |
PRE Prenetics Global | $4.61 -7.2% | 4/4/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $9.00 | Low | View details for Cantor Fitzgerald rating of Prenetics Global (NASDAQ:PRE) on 4/4/2024 |
CNC Centene | $74.00 -2.2% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $90.00 | Low | View details for Cantor Fitzgerald rating of Centene (NYSE:CNC) on 4/4/2024 |
CVS CVS Health | $67.18 -0.2% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $87.00 | Low | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 4/4/2024 |
ELV Elevance Health | $537.26 -0.4% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $580.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 4/4/2024 |
HUM Humana | $305.91 -1.8% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $391.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 4/4/2024 |
TNGX Tango Therapeutics | $7.44 +1.5% | 4/4/2024 | Initiated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of Tango Therapeutics (NASDAQ:TNGX) on 4/4/2024 |
INTC Intel | $31.88 -9.2% | 4/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $50.00 | Low | View details for Cantor Fitzgerald rating of Intel (NASDAQ:INTC) on 4/3/2024 |
How a $0.25 cent option contract makes my top traders feel (Ad) If you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time!
While I kept the finer details of these $0.25 Cent Trades under wraps until recently… Click now to see for yourself what $0.25 Cent Trades is all about |
ANNX Annexon | $4.70 +2.4% | 4/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Annexon (NASDAQ:ANNX) on 4/3/2024 |
PRCH Porch Group | $3.47 +8.1% | 4/3/2024 | Target Raised by | Cantor Fitzgerald | Analyst J. Siegler | Overweight -> Overweight | $3.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of Porch Group (NASDAQ:PRCH) on 4/3/2024 |
RIVN Rivian Automotive | $9.04 +6.1% | 4/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $23.00 | Low | View details for Cantor Fitzgerald rating of Rivian Automotive (NASDAQ:RIVN) on 4/3/2024 |
LEGN Legend Biotech | $45.30 +2.0% | 4/3/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $82.00 | Low | View details for Cantor Fitzgerald rating of Legend Biotech (NASDAQ:LEGN) on 4/3/2024 |
AFMD Affimed | $5.03 +3.1% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Affimed (NASDAQ:AFMD) on 4/1/2024 |
CRVS Corvus Pharmaceuticals | $1.45 -2.0% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 4/1/2024 |
VINC Vincerx Pharma | $0.73 -18.9% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Vincerx Pharma (NASDAQ:VINC) on 4/1/2024 |
ATNM Actinium Pharmaceuticals | $6.87 +4.7% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $21.00 | N/A | View details for Cantor Fitzgerald rating of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) on 4/1/2024 |
AWH Aspira Women's Health | $3.33 +1.5% | 4/1/2024 | Target Lowered by | Cantor Fitzgerald | - | Neutral -> Neutral | $4.00 -> $3.30 | Low | View details for Cantor Fitzgerald rating of Aspira Women’s Health (NASDAQ:AWH) on 4/1/2024 |
HUMA Humacyte | $3.99 +2.3% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Humacyte (NASDAQ:HUMA) on 4/1/2024 |
ZVRA Zevra Therapeutics | $4.52
| 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 4/1/2024 |
SCYX SCYNEXIS | $1.54 +4.8% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of SCYNEXIS (NASDAQ:SCYX) on 4/1/2024 |
ASND Ascendis Pharma A/S | $135.90 -0.8% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $173.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 4/1/2024 |
LLY Eli Lilly and Company | $733.51 +1.2% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $815.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 4/1/2024 |
NVO Novo Nordisk A/S | $126.86 +0.9% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $160.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 4/1/2024 |
PFE Pfizer | $25.38 +0.5% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 4/1/2024 |
MIGI Mawson Infrastructure Group | $1.38 -0.7% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $1.00 | Low | View details for Cantor Fitzgerald rating of Mawson Infrastructure Group (NASDAQ:MIGI) on 4/1/2024 |
EVLV Evolv Technologies | $4.13 +4.8% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | N/A | View details for Cantor Fitzgerald rating of Evolv Technologies (NASDAQ:EVLV) on 3/28/2024 |
CMCL Caledonia Mining | $9.99 -1.4% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Speculative Buy -> Hold | | N/A | View details for Cantor Fitzgerald rating of Caledonia Mining (NYSEAMERICAN:CMCL) on 3/28/2024 |
CLSK CleanSpark | $19.23 -1.6% | 3/28/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $20.00 | N/A | View details for Cantor Fitzgerald rating of CleanSpark (NASDAQ:CLSK) on 3/28/2024 |
BITF Bitfarms | $1.96 -2.0% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 | N/A | View details for Cantor Fitzgerald rating of Bitfarms (NASDAQ:BITF) on 3/28/2024 |
CIFR Cipher Mining | $4.50 +1.6% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 | N/A | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 3/28/2024 |
IREN Iris Energy | $5.08 -1.7% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | N/A | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 3/28/2024 |
RIOT Riot Platforms | $11.93 -1.5% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 3/28/2024 |
WULF TeraWulf | $2.47 -0.8% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 | N/A | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 3/28/2024 |
OUST Ouster | $8.67 +15.9% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | N/A | View details for Cantor Fitzgerald rating of Ouster (NYSE:OUST) on 3/28/2024 |
MREO Mereo BioPharma Group | $2.74 -2.5% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | N/A | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 3/28/2024 |
HRMY Harmony Biosciences | $29.32 +1.3% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 | N/A | View details for Cantor Fitzgerald rating of Harmony Biosciences (NASDAQ:HRMY) on 3/28/2024 |
CXM Sprinklr | $11.93 +0.8% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $16.00 | N/A | View details for Cantor Fitzgerald rating of Sprinklr (NYSE:CXM) on 3/28/2024 |
ZS Zscaler | $177.05 +1.3% | 3/27/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $230.00 | Low | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 3/27/2024 |
MRK Merck & Co., Inc. | $131.19 +0.4% | 3/27/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 3/27/2024 |
VNRX VolitionRx | $0.91 +2.2% | 3/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $2.50 | Low | View details for Cantor Fitzgerald rating of VolitionRx (NYSE:VNRX) on 3/27/2024 |
SMTI Sanara MedTech | $32.35 +0.4% | 3/27/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 -> $44.00 | Low | View details for Cantor Fitzgerald rating of Sanara MedTech (NASDAQ:SMTI) on 3/27/2024 |
LUCD Lucid Diagnostics | $0.68 +1.5% | 3/27/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.80 -> $3.00 | Low | View details for Cantor Fitzgerald rating of Lucid Diagnostics (NASDAQ:LUCD) on 3/27/2024 |
LUNR Intuitive Machines | $5.44 +0.2% | 3/22/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 -> $10.00 | Low | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 3/22/2024 |
JAZZ Jazz Pharmaceuticals | $109.46 +1.9% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 3/22/2024 |
CLDX Celldex Therapeutics | $36.30 +0.1% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $67.00 | Low | View details for Cantor Fitzgerald rating of Celldex Therapeutics (NASDAQ:CLDX) on 3/22/2024 |
CABA Cabaletta Bio | $11.01 -9.6% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 | Low | View details for Cantor Fitzgerald rating of Cabaletta Bio (NASDAQ:CABA) on 3/22/2024 |
DESP Despegar.com | $12.82 +0.4% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 | Low | View details for Cantor Fitzgerald rating of Despegar.com (NYSE:DESP) on 3/22/2024 |
MREO Mereo BioPharma Group | $2.74 -2.5% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 3/22/2024 |
CPRX Catalyst Pharmaceuticals | $14.89 +1.4% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $34.00 | Low | View details for Cantor Fitzgerald rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/22/2024 |
SOUN SoundHound AI | $4.40 +5.8% | 3/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Underweight | $5.80 -> $4.90 | Low | View details for Cantor Fitzgerald rating of SoundHound AI (NASDAQ:SOUN) on 3/20/2024 |
NVO Novo Nordisk A/S | $126.86 +0.9% | 3/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $160.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 3/20/2024 |
TSHA Taysha Gene Therapies | $2.39 +3.9% | 3/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 3/20/2024 |
WULF TeraWulf | $2.47 -0.8% | 3/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 | Low | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 3/20/2024 |
JANX Janux Therapeutics | $47.39 +0.6% | 3/20/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $100.00 | Low | View details for Cantor Fitzgerald rating of Janux Therapeutics (NASDAQ:JANX) on 3/20/2024 |
BBIO BridgeBio Pharma | $24.88 +2.3% | 3/19/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 -> $70.00 | Low | View details for Cantor Fitzgerald rating of BridgeBio Pharma (NASDAQ:BBIO) on 3/19/2024 |
SHLS Shoals Technologies Group | $8.52 +3.1% | 3/13/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of Shoals Technologies Group (NASDAQ:SHLS) on 3/13/2024 |
LBPH Longboard Pharmaceuticals | $19.72 +2.4% | 3/13/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 3/13/2024 |
GDYN Grid Dynamics | $9.93 -0.1% | 3/13/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 -> $17.00 | Low | View details for Cantor Fitzgerald rating of Grid Dynamics (NASDAQ:GDYN) on 3/13/2024 |
How a $0.25 cent option contract makes my top traders feel (Ad) If you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time!
While I kept the finer details of these $0.25 Cent Trades under wraps until recently… Click now to see for yourself what $0.25 Cent Trades is all about |
JNJ Johnson & Johnson | $146.13 -0.5% | 3/13/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 3/13/2024 |
CRWD CrowdStrike | $304.07 +2.0% | 3/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $400.00 | Low | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 3/14/2024 |
CPRX Catalyst Pharmaceuticals | $14.89 +1.4% | 3/14/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $34.00 | Low | View details for Cantor Fitzgerald rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/14/2024 |
MNKD MannKind | $4.23 +1.2% | 3/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.50 | Low | View details for Cantor Fitzgerald rating of MannKind (NASDAQ:MNKD) on 3/15/2024 |
DESP Despegar.com | $12.82 +0.4% | 3/15/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $11.00 -> $14.00 | Low | View details for Cantor Fitzgerald rating of Despegar.com (NYSE:DESP) on 3/15/2024 |
SSTI SoundThinking | $13.67 +1.8% | 3/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of SoundThinking (NASDAQ:SSTI) on 3/15/2024 |
MU Micron Technology | $114.84 +2.9% | 3/18/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $100.00 -> $120.00 | Low | View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 3/18/2024 |
RNA Avidity Biosciences | $24.36 +2.2% | 3/14/2024 | Initiated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Avidity Biosciences (NASDAQ:RNA) on 3/14/2024 |
FROG JFrog | $41.99 +3.8% | 3/7/2024 | Target Raised by | Cantor Fitzgerald | - | | $40.00 -> $45.00 | Low | View details for Cantor Fitzgerald rating of JFrog (NASDAQ:FROG) on 3/7/2024 |
EVGO EVgo | $1.81 +5.8% | 3/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Neutral | $5.00 | Low | View details for Cantor Fitzgerald rating of EVgo (NYSE:EVGO) on 3/7/2024 |
ISPO Inspirato | $3.99 +2.3% | 3/7/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $19.00 -> $18.00 | N/A | View details for Cantor Fitzgerald rating of Inspirato (NASDAQ:ISPO) on 3/7/2024 |
DESP Despegar.com | $12.82 +0.4% | 3/7/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $11.00 | Low | View details for Cantor Fitzgerald rating of Despegar.com (NYSE:DESP) on 3/7/2024 |
CIFR Cipher Mining | $4.50 +1.6% | 3/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 3/6/2024 |
NPCE NeuroPace | $13.39 +3.1% | 3/6/2024 | Target Raised by | Cantor Fitzgerald | Analyst R. Osborn | Overweight -> Overweight | $16.00 -> $18.00 | Low | View details for Cantor Fitzgerald rating of NeuroPace (NASDAQ:NPCE) on 3/6/2024 |
CERS Cerus | $1.71 +0.6% | 3/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 | Low | View details for Cantor Fitzgerald rating of Cerus (NASDAQ:CERS) on 3/6/2024 |
CRWD CrowdStrike | $304.07 +2.0% | 3/6/2024 | Target Raised by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $360.00 -> $400.00 | N/A | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024 |
RIGL Rigel Pharmaceuticals | $1.10
| 3/6/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $2.00 -> $3.00 | Low | View details for Cantor Fitzgerald rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 3/6/2024 |
THC Tenet Healthcare | $96.13 -1.4% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $104.00 | Low | View details for Cantor Fitzgerald rating of Tenet Healthcare (NYSE:THC) on 3/5/2024 |
ACHC Acadia Healthcare | $73.59 +0.3% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $90.00 | Low | View details for Cantor Fitzgerald rating of Acadia Healthcare (NASDAQ:ACHC) on 3/5/2024 |
HCA HCA Healthcare | $306.60 -2.4% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $335.00 | Low | View details for Cantor Fitzgerald rating of HCA Healthcare (NYSE:HCA) on 3/5/2024 |
HCAT Health Catalyst | $6.03 +7.7% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $16.00 | Low | View details for Cantor Fitzgerald rating of Health Catalyst (NASDAQ:HCAT) on 3/5/2024 |
RCM R1 RCM | $11.90 +0.7% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | Low | View details for Cantor Fitzgerald rating of R1 RCM (NASDAQ:RCM) on 3/5/2024 |
SGRY Surgery Partners | $24.55 -1.2% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $43.00 | Low | View details for Cantor Fitzgerald rating of Surgery Partners (NASDAQ:SGRY) on 3/5/2024 |
TBRG TruBridge | $8.04 +2.4% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of TruBridge (NASDAQ:TBRG) on 3/5/2024 |
GTLB GitLab | $55.46 -1.0% | 3/5/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $80.00 -> $70.00 | Low | View details for Cantor Fitzgerald rating of GitLab (NASDAQ:GTLB) on 3/5/2024 |
NVDA NVIDIA | $877.35 +6.2% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $900.00 | N/A | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 3/4/2024 |
NXPI NXP Semiconductors | $242.70 +1.9% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $270.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 3/4/2024 |
TXN Texas Instruments | $177.48 +1.3% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $170.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 3/4/2024 |
QCOM QUALCOMM | $165.66 +1.4% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $150.00 | Low | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 3/4/2024 |
TER Teradyne | $114.13 +4.8% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $110.00 | Low | View details for Cantor Fitzgerald rating of Teradyne (NASDAQ:TER) on 3/4/2024 |
STX Seagate Technology | $86.04 -1.4% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $95.00 | Low | View details for Cantor Fitzgerald rating of Seagate Technology (NASDAQ:STX) on 3/4/2024 |
AVGO Broadcom | $1,344.07 +3.8% | 3/4/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $1,300.00 -> $1,600.00 | Low | View details for Cantor Fitzgerald rating of Broadcom (NASDAQ:AVGO) on 3/4/2024 |
AMAT Applied Materials | $203.38 +3.0% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $220.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 3/4/2024 |
AMD Advanced Micro Devices | $157.40 +2.4% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $190.00 | Low | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 3/4/2024 |
KLAC KLA | $706.26 +4.9% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $625.00 | Low | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 3/4/2024 |
LRCX Lam Research | $925.37 +2.7% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $900.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 3/4/2024 |
ADI Analog Devices | $201.97 +2.0% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $205.00 | Low | View details for Cantor Fitzgerald rating of Analog Devices (NASDAQ:ADI) on 3/4/2024 |
CI The Cigna Group | $354.41 0.0% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Overweight -> Overweight | $372.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 3/4/2024 |
PAGS PagSeguro Digital | $12.68 +7.3% | 3/4/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 -> $16.00 | Low | View details for Cantor Fitzgerald rating of PagSeguro Digital (NYSE:PAGS) on 3/4/2024 |
CRNX Crinetics Pharmaceuticals | $42.12 -0.4% | 3/4/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 -> $65.00 | Low | View details for Cantor Fitzgerald rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/4/2024 |
RIOT Riot Platforms | $11.93 -1.5% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 3/4/2024 |
ETNB 89bio | $8.26 +0.1% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $29.00 | Low | View details for Cantor Fitzgerald rating of 89bio (NASDAQ:ETNB) on 3/4/2024 |
BBAI BigBear.ai | $1.80 +8.4% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 | Low | View details for Cantor Fitzgerald rating of BigBear.ai (NYSE:BBAI) on 3/4/2024 |
EVLV Evolv Technologies | $4.13 +4.8% | 3/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | Low | View details for Cantor Fitzgerald rating of Evolv Technologies (NASDAQ:EVLV) on 3/1/2024 |
PTCT PTC Therapeutics | $28.57 +12.1% | 3/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 3/1/2024 |
AVPT AvePoint | $8.13 +2.7% | 3/1/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $11.00 | Low | View details for Cantor Fitzgerald rating of AvePoint (NASDAQ:AVPT) on 3/1/2024 |
SOUN SoundHound AI | $4.40 +5.8% | 3/1/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.60 -> $5.80 | Low | View details for Cantor Fitzgerald rating of SoundHound AI (NASDAQ:SOUN) on 3/1/2024 |
MVIS MicroVision | $1.50 +5.6% | 3/1/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $3.00 | Low | View details for Cantor Fitzgerald rating of MicroVision (NASDAQ:MVIS) on 3/1/2024 |
PFE Pfizer | $25.38 +0.5% | 3/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 3/1/2024 |
ZS Zscaler | $177.05 +1.3% | 3/1/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $250.00 -> $230.00 | Low | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 3/1/2024 |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
CPRX Catalyst Pharmaceuticals | $14.89 +1.4% | 3/1/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $27.00 -> $34.00 | Low | View details for Cantor Fitzgerald rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/1/2024 |
PAYO Payoneer Global | $5.01 +1.6% | 3/1/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 -> $7.00 | Low | View details for Cantor Fitzgerald rating of Payoneer Global (NASDAQ:PAYO) on 3/1/2024 |
ORGO Organogenesis | $2.35 +2.6% | 3/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight -> Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Organogenesis (NASDAQ:ORGO) on 3/1/2024 |
MIRM Mirum Pharmaceuticals | $24.46 -0.1% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $35.00 | Low | View details for Cantor Fitzgerald rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 2/29/2024 |
SRPT Sarepta Therapeutics | $128.77 +1.1% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $128.00 | Low | View details for Cantor Fitzgerald rating of Sarepta Therapeutics (NASDAQ:SRPT) on 2/29/2024 |
SHLS Shoals Technologies Group | $8.52 +3.1% | 2/29/2024 | Target Lowered by | Cantor Fitzgerald | Analyst D. Soderberg | Overweight -> Overweight | $28.00 -> $24.00 | Low | View details for Cantor Fitzgerald rating of Shoals Technologies Group (NASDAQ:SHLS) on 2/29/2024 |
CYBR CyberArk Software | $242.60 -1.0% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $300.00 | Low | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 2/29/2024 |
MRK Merck & Co., Inc. | $131.19 +0.4% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 2/29/2024 |
FOLD Amicus Therapeutics | $10.28 +1.1% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $22.00 | Low | View details for Cantor Fitzgerald rating of Amicus Therapeutics (NASDAQ:FOLD) on 2/29/2024 |
DCGO DocGo | $3.61 +3.4% | 2/29/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 -> $11.00 | Low | View details for Cantor Fitzgerald rating of DocGo (NASDAQ:DCGO) on 2/29/2024 |
ADMA ADMA Biologics | $6.55 +1.7% | 2/29/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.50 -> $8.00 | Low | View details for Cantor Fitzgerald rating of ADMA Biologics (NASDAQ:ADMA) on 2/29/2024 |
LUNR Intuitive Machines | $5.44 +0.2% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 | Low | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 2/29/2024 |
UHS Universal Health Services | $166.06 +0.6% | 2/29/2024 | Target Raised by | Cantor Fitzgerald | - | Underweight -> Underweight | $148.00 -> $156.00 | Low | View details for Cantor Fitzgerald rating of Universal Health Services (NYSE:UHS) on 2/29/2024 |
JAZZ Jazz Pharmaceuticals | $109.46 +1.9% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 2/29/2024 |
TDOC Teladoc Health | $13.01 -2.4% | 2/29/2024 | Initiated by | Cantor Fitzgerald | Analyst S. James | Overweight | $22.00 | Low | View details for Cantor Fitzgerald rating of Teladoc Health (NYSE:TDOC) on 2/29/2024 |
MNKD MannKind | $4.23 +1.2% | 2/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.50 | Low | View details for Cantor Fitzgerald rating of MannKind (NASDAQ:MNKD) on 2/28/2024 |
ACAD ACADIA Pharmaceuticals | $16.71 +2.5% | 2/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $42.00 | Low | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 2/28/2024 |
ARRY Array Technologies | $12.40 +3.9% | 2/28/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $22.00 -> $18.00 | N/A | View details for Cantor Fitzgerald rating of Array Technologies (NASDAQ:ARRY) on 2/28/2024 |
SSTI SoundThinking | $13.67 +1.8% | 2/28/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of SoundThinking (NASDAQ:SSTI) on 2/28/2024 |
PGNY Progyny | $32.04 -1.4% | 2/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $48.00 | Low | View details for Cantor Fitzgerald rating of Progyny (NASDAQ:PGNY) on 2/28/2024 |
MKFG Markforged | $0.67 -1.5% | 2/28/2024 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight | $1.45 | Low | View details for Cantor Fitzgerald rating of Markforged (NYSE:MKFG) on 2/28/2024 |
DM Desktop Metal | $0.82
| 2/28/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $1.25 | Low | View details for Cantor Fitzgerald rating of Desktop Metal (NYSE:DM) on 2/28/2024 |
SIBN SI-BONE | $14.57 +2.1% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of SI-BONE (NASDAQ:SIBN) on 2/27/2024 |
ACHR Archer Aviation | $4.02 +0.8% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | Low | View details for Cantor Fitzgerald rating of Archer Aviation (NYSE:ACHR) on 2/27/2024 |
RARE Ultragenyx Pharmaceutical | $44.24 +0.9% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 2/27/2024 |
BBAI BigBear.ai | $1.80 +8.4% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 | Low | View details for Cantor Fitzgerald rating of BigBear.ai (NYSE:BBAI) on 2/27/2024 |
RCKT Rocket Pharmaceuticals | $21.98 -0.5% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 2/27/2024 |
SGRY Surgery Partners | $24.55 -1.2% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $43.00 | Low | View details for Cantor Fitzgerald rating of Surgery Partners (NASDAQ:SGRY) on 2/27/2024 |
GENI Genius Sports | $5.20 +0.6% | 2/26/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | Low | View details for Cantor Fitzgerald rating of Genius Sports (NYSE:GENI) on 2/26/2024 |
BMRN BioMarin Pharmaceutical | $80.91 -1.5% | 2/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $100.00 | Low | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 2/23/2024 |
HRMY Harmony Biosciences | $29.32 +1.3% | 2/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 | Low | View details for Cantor Fitzgerald rating of Harmony Biosciences (NASDAQ:HRMY) on 2/23/2024 |
WULF TeraWulf | $2.47 -0.8% | 2/23/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 -> $4.00 | Low | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 2/23/2024 |
LUNR Intuitive Machines | $5.44 +0.2% | 2/23/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 -> $13.00 | Low | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 2/23/2024 |
RIOT Riot Platforms | $11.93 -1.5% | 2/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $19.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 2/23/2024 |
RCEL AVITA Medical | $8.52 +2.7% | 2/23/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $22.00 -> $25.00 | Low | View details for Cantor Fitzgerald rating of AVITA Medical (NASDAQ:RCEL) on 2/23/2024 |
AUPH Aurinia Pharmaceuticals | $4.91 +0.8% | 2/23/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $12.00 -> $10.00 | Low | View details for Cantor Fitzgerald rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 2/23/2024 |
ITCI Intra-Cellular Therapies | $73.26 +1.6% | 2/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $101.00 | Low | View details for Cantor Fitzgerald rating of Intra-Cellular Therapies (NASDAQ:ITCI) on 2/23/2024 |
ORIC ORIC Pharmaceuticals | $8.07 +5.2% | 2/23/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 2/23/2024 |
LCID Lucid Group | $2.46 +0.4% | 2/22/2024 | Downgraded by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Underweight | $6.00 -> $4.00 | Low | View details for Cantor Fitzgerald rating of Lucid Group (NASDAQ:LCID) on 2/22/2024 |
ROOT Root | $64.40 +2.8% | 2/22/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Siegler | Neutral -> Overweight | $9.00 -> $13.00 | Low | View details for Cantor Fitzgerald rating of Root (NASDAQ:ROOT) on 2/22/2024 |
ENVX Enovix | $6.46 +10.6% | 2/21/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 | Low | View details for Cantor Fitzgerald rating of Enovix (NASDAQ:ENVX) on 2/21/2024 |
PANW Palo Alto Networks | $291.42 +0.9% | 2/21/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $400.00 -> $350.00 | Low | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 2/21/2024 |
SPT Sprout Social | $51.39 +0.1% | 2/21/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $74.00 | Low | View details for Cantor Fitzgerald rating of Sprout Social (NASDAQ:SPT) on 2/21/2024 |
SABR Sabre | $2.80 +1.4% | 2/21/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Sabre (NASDAQ:SABR) on 2/21/2024 |
ALNY Alnylam Pharmaceuticals | $143.31 -0.3% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $165.00 | Low | View details for Cantor Fitzgerald rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 2/20/2024 |
AXSM Axsome Therapeutics | $71.71 +0.3% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $108.00 | Low | View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 2/20/2024 |
BIIB Biogen | $208.90 +3.2% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight -> Overweight | $311.00 | Low | View details for Cantor Fitzgerald rating of Biogen (NASDAQ:BIIB) on 2/20/2024 |
JNJ Johnson & Johnson | $146.13 -0.5% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 2/20/2024 |
KRTX Karuna Therapeutics | $329.83
| 2/20/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $330.00 | Low | View details for Cantor Fitzgerald rating of Karuna Therapeutics (NASDAQ:KRTX) on 2/20/2024 |
LLY Eli Lilly and Company | $733.51 +1.2% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $815.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 2/20/2024 |
NVO Novo Nordisk A/S | $126.86 +0.9% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $140.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 2/20/2024 |
VRTX Vertex Pharmaceuticals | $397.48 -0.1% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $440.00 | Low | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 2/20/2024 |
ADI Analog Devices | $201.97 +2.0% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $205.00 | Low | View details for Cantor Fitzgerald rating of Analog Devices (NASDAQ:ADI) on 2/20/2024 |
AMAT Applied Materials | $203.38 +3.0% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $220.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 2/20/2024 |
AMD Advanced Micro Devices | $157.40 +2.4% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $190.00 | Low | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 2/20/2024 |
AVGO Broadcom | $1,344.07 +3.8% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $1,300.00 | Low | View details for Cantor Fitzgerald rating of Broadcom (NASDAQ:AVGO) on 2/20/2024 |
KLAC KLA | $706.26 +4.9% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $625.00 | Low | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 2/20/2024 |
LRCX Lam Research | $925.37 +2.7% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $900.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 2/20/2024 |
NVDA NVIDIA | $877.35 +6.2% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $775.00 -> $900.00 | Low | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 2/20/2024 |
NXPI NXP Semiconductors | $242.70 +1.9% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $270.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 2/20/2024 |